Cannabinoid formulation benefits opioid-refractory pain
(HealthDay) -- A novel cannabinoid formulation, nabiximols, is safe and effective for patients with advanced cancer and opioid-refractory pain, especially at a low-dose, according to a study published in the May issue of ...
Jun 13, 2012
0
0